Recent developments in the chemotherapy of leishmaniasis
- 1 October 1988
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 9 (10) , 376-381
- https://doi.org/10.1016/0165-6147(88)90258-1
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- LeishmaniasisPublished by Elsevier ,2012
- Topical chemotherapy of cutaneous LeishmaniasisParasitology Today, 1988
- Topical Therapy of Cutaneous Leishmaniasis With 2% Ketoconazole Ointment and DMSOInternational Journal of Dermatology, 1987
- Antileishmanial activity of liposome-encapsulated amphotericin B in hamsters and monkeysAntimicrobial Agents and Chemotherapy, 1986
- Liposomes as drug carriers in leishmaniasis and malariaParasitology Today, 1986
- Anti-leishmanial effect of allopurinol ribonucleoside and the related compounds, allopurinol, thiopurinol, thiopurinol ribonucleoside, and of formycin B, sinefungin and the lepidine WR6026Transactions of the Royal Society of Tropical Medicine and Hygiene, 1985
- Development of topical treatment for cutaneous leishmaniasis caused by Leishmania major in experimental animalsAntimicrobial Agents and Chemotherapy, 1984
- Pyrazolopyrimidine Metabolism in Parasitic ProtozoaPharmaceutical Research, 1984
- Tissue distribution and fate of free and liposome-encapsulated [125Sb]sodium stibogluconate by gamma scinligraphyInternational Journal of Pharmaceutics, 1983
- Pyrazolopyrimidine metabolism in the pathogenic trypanosomatidaeMolecular and Biochemical Parasitology, 1983